• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠肿瘤和黏膜中的鸟氨酸脱羧酶与多胺

Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.

作者信息

Hixson L J, Garewal H S, McGee D L, Sloan D, Fennerty M B, Sampliner R E, Gerner E W

机构信息

Department of Internal Medicine, University of Arizona, Tucson 85724.

出版信息

Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):369-74.

PMID:8348060
Abstract

Ornithine decarboxylase (ODC) and polyamines are intimately involved in normal cellular proliferation and are likely to play a role in carcinogenesis. ODC activity and polyamine content were measured in tissue samples obtained during colonoscopy from 48 benign neoplastic polyps (20 tubular adenomas; 28 villous adenomas), 18 cancers (including 5 malignant polyps), and adjacent mucosa. ODC activity in polyp and cancer tissue specimens was higher than in adjacent mucosa in 75 and 83% of pairs, respectively. Similarly, putrescine, spermidine, and spermine contents were higher in the majority of polyps and cancers compared to adjacent mucosa. ODC activity and polyamine content in colonic mucosa from 10 patients without a history of colorectal neoplasia were not different from adjacent mucosal values in the patients with neoplasia. In conclusion, ODC and polyamines are elevated in the majority of colorectal neoplasms, but amounts in normal mucosa do not differentiate between patients with cancer, benign neoplastic polyps, and normal subjects.

摘要

鸟氨酸脱羧酶(ODC)和多胺与正常细胞增殖密切相关,且可能在致癌过程中发挥作用。在结肠镜检查期间从48个良性肿瘤性息肉(20个管状腺瘤;28个绒毛状腺瘤)、18例癌症(包括5个恶性息肉)及相邻黏膜获取的组织样本中,检测了ODC活性和多胺含量。息肉和癌组织标本中的ODC活性分别在75%和83%的样本对中高于相邻黏膜。同样,与相邻黏膜相比,大多数息肉和癌症中的腐胺、亚精胺和精胺含量更高。10例无结直肠肿瘤病史患者的结肠黏膜中的ODC活性和多胺含量与有肿瘤患者的相邻黏膜值无差异。总之,大多数结直肠肿瘤中ODC和多胺水平升高,但正常黏膜中的含量在癌症患者、良性肿瘤性息肉患者和正常受试者之间并无差异。

相似文献

1
Ornithine decarboxylase and polyamines in colorectal neoplasia and mucosa.结直肠肿瘤和黏膜中的鸟氨酸脱羧酶与多胺
Cancer Epidemiol Biomarkers Prev. 1993 Jul-Aug;2(4):369-74.
2
Sources of variability in estimating ornithine decarboxylase activity and polyamine contents in human colorectal mucosa.人结肠黏膜中鸟氨酸脱羧酶活性和多胺含量估计的变异性来源。
Cancer Epidemiol Biomarkers Prev. 1994 Jun;3(4):317-23.
3
Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa.结直肠癌及正常周围黏膜中的多胺、二胺氧化酶和鸟氨酸脱羧酶活性
Dis Colon Rectum. 1993 Jul;36(7):662-7. doi: 10.1007/BF02238593.
4
Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade.人类结肠腺癌的多胺水平与肿瘤分期和分级相关。
Int J Colorectal Dis. 2002 Nov;17(6):381-7. doi: 10.1007/s00384-002-0394-7. Epub 2002 Apr 20.
5
Ornithine decarboxylase and polyamines in familial adenomatous polyposis.家族性腺瘤性息肉病中的鸟氨酸脱羧酶和多胺
Cancer Res. 1997 Jan 15;57(2):199-201.
6
High ornithine decarboxylase activity and polyamine levels in human colorectal neoplasia.人类结直肠癌中鸟氨酸脱羧酶活性和多胺水平较高。
Ann Surg. 1986 Jul;204(1):89-93. doi: 10.1097/00000658-198607000-00013.
7
Colonic polyamine content and ornithine decarboxylase activity as markers for adenomas.结肠多胺含量和鸟氨酸脱羧酶活性作为腺瘤的标志物
Cancer. 1990 Oct 1;66(7):1539-43. doi: 10.1002/1097-0142(19901001)66:7<1539::aid-cncr2820660718>3.0.co;2-z.
8
Ornithine decarboxylase: an unreliable marker for the identification of population groups at risk for colonic neoplasia.鸟氨酸脱羧酶:一种用于识别患结肠肿瘤风险人群组的不可靠标志物。
Am J Gastroenterol. 1990 Jun;85(6):723-6.
9
Polyamine levels, ornithine decarboxylase (ODC) activity, and ODC-mRNA expression in normal and cancerous human colonocytes.正常和癌性人结肠细胞中的多胺水平、鸟氨酸脱羧酶(ODC)活性及ODC-mRNA表达。
Life Sci. 1992;50(19):1417-24. doi: 10.1016/0024-3205(92)90260-v.
10
Polyamine contents in rectal and buccal mucosae in humans treated with oral difluoromethylornithine.口服二氟甲基鸟氨酸治疗的人体直肠和颊黏膜中的多胺含量
Cancer Epidemiol Biomarkers Prev. 1992 Jan-Feb;1(2):131-5.

引用本文的文献

1
Polyamine Inhibition with DFMO: Shifting the Paradigm in Neuroblastoma Therapy.用二氟甲基鸟氨酸进行多胺抑制:改变神经母细胞瘤治疗的模式
J Clin Med. 2025 Feb 7;14(4):1068. doi: 10.3390/jcm14041068.
2
Chemoprevention of Colon Cancer by DFMO, Sulindac, and NO-Sulindac Administered Individually or in Combinations in F344 Rats.在F344大鼠中单独或联合给予二氟甲基鸟氨酸(DFMO)、舒林酸和去亚砜舒林酸对结肠癌的化学预防作用
Cancers (Basel). 2023 Aug 7;15(15):4001. doi: 10.3390/cancers15154001.
3
A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high-risk neuroblastoma.
一项评估 DFMO 作为高危神经母细胞瘤维持治疗的 II 期试验的亚组分析。
Int J Cancer. 2020 Dec 1;147(11):3152-3159. doi: 10.1002/ijc.33044. Epub 2020 May 24.
4
Maintenance DFMO Increases Survival in High Risk Neuroblastoma.维持 DFMO 可提高高危神经母细胞瘤患者的生存率。
Sci Rep. 2018 Sep 27;8(1):14445. doi: 10.1038/s41598-018-32659-w.
5
Cystathionine-beta-synthase inhibition for colon cancer: Enhancement of the efficacy of aminooxyacetic acid via the prodrug approach.胱硫醚-β-合酶抑制用于结肠癌:通过前药方法增强氨基氧乙酸的疗效。
Mol Med. 2016 Sep;22:361-379. doi: 10.2119/molmed.2016.00102. Epub 2016 May 16.
6
Dietary polyamine intake and colorectal cancer risk in postmenopausal women.绝经后女性膳食多胺摄入量与结直肠癌风险
Am J Clin Nutr. 2015 Aug;102(2):411-9. doi: 10.3945/ajcn.114.103895. Epub 2015 Jul 1.
7
Targeting ornithine decarboxylase reverses the LIN28/Let-7 axis and inhibits glycolytic metabolism in neuroblastoma.靶向鸟氨酸脱羧酶可逆转LIN28/Let-7轴并抑制神经母细胞瘤中的糖酵解代谢。
Oncotarget. 2015 Jan 1;6(1):196-206. doi: 10.18632/oncotarget.2768.
8
Dietary polyamine intake and risk of colorectal adenomatous polyps.饮食多胺摄入与结直肠腺瘤性息肉风险的关系。
Am J Clin Nutr. 2012 Jul;96(1):133-41. doi: 10.3945/ajcn.111.030353. Epub 2012 May 30.
9
DFMO: targeted risk reduction therapy for colorectal neoplasia.DFMO:结直肠肿瘤的靶向风险降低治疗。
Best Pract Res Clin Gastroenterol. 2011 Aug;25(4-5):495-506. doi: 10.1016/j.bpg.2011.09.007.
10
The mechanisms by which polyamines accelerate tumor spread.多胺加速肿瘤扩散的机制。
J Exp Clin Cancer Res. 2011 Oct 11;30(1):95. doi: 10.1186/1756-9966-30-95.